CN102134187B - 檵木叶中的4-(4-羟基-3-甲氧苯基)-1-(4-羟苯基)-2,3-二甲基丁基-1-酮及其用途 - Google Patents
檵木叶中的4-(4-羟基-3-甲氧苯基)-1-(4-羟苯基)-2,3-二甲基丁基-1-酮及其用途 Download PDFInfo
- Publication number
- CN102134187B CN102134187B CN201110053465XA CN201110053465A CN102134187B CN 102134187 B CN102134187 B CN 102134187B CN 201110053465X A CN201110053465X A CN 201110053465XA CN 201110053465 A CN201110053465 A CN 201110053465A CN 102134187 B CN102134187 B CN 102134187B
- Authority
- CN
- China
- Prior art keywords
- methoxyphenyl
- ketone
- phenylor
- dimethylbutyl
- hydroxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000906054 Loropetalum Species 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000007902 hard capsule Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 241001312524 Streptococcus viridans Species 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 230000000968 intestinal effect Effects 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 claims 1
- 241001478240 Coccus Species 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 abstract description 6
- 210000002540 macrophage Anatomy 0.000 abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- 230000008733 trauma Effects 0.000 abstract description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N methyl alcohol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- 238000010828 elution Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 206010053615 Thermal burn Diseases 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 229960001866 silicon dioxide Drugs 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229920006008 lipopolysaccharide Polymers 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- -1 polyoxyethylene Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- XCEBPBXELZPDPH-UHFFFAOYSA-N 4-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-2,3-dimethylbutan-1-one Chemical compound C1=C(O)C(OC)=CC(CC(C)C(C)C(=O)C=2C=CC(O)=CC=2)=C1 XCEBPBXELZPDPH-UHFFFAOYSA-N 0.000 description 1
- XCEBPBXELZPDPH-QWHCGFSZSA-N 4-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-2,3-dimethylbutan-1-one Natural products COc1cc(C[C@H](C)[C@@H](C)C(=O)c2ccc(O)cc2)ccc1O XCEBPBXELZPDPH-QWHCGFSZSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005100 correlation spectroscopy Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000001257 hydrogen Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Natural products CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110053465XA CN102134187B (zh) | 2011-03-07 | 2011-03-07 | 檵木叶中的4-(4-羟基-3-甲氧苯基)-1-(4-羟苯基)-2,3-二甲基丁基-1-酮及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110053465XA CN102134187B (zh) | 2011-03-07 | 2011-03-07 | 檵木叶中的4-(4-羟基-3-甲氧苯基)-1-(4-羟苯基)-2,3-二甲基丁基-1-酮及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102134187A CN102134187A (zh) | 2011-07-27 |
CN102134187B true CN102134187B (zh) | 2012-07-25 |
Family
ID=44294142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110053465XA Expired - Fee Related CN102134187B (zh) | 2011-03-07 | 2011-03-07 | 檵木叶中的4-(4-羟基-3-甲氧苯基)-1-(4-羟苯基)-2,3-二甲基丁基-1-酮及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102134187B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579524A (zh) * | 2012-03-28 | 2012-07-18 | 江西徳宇集团 | 白花檵木提取物在制备愈伤药物中的应用 |
CN110389214A (zh) * | 2019-07-23 | 2019-10-29 | 广州鲁比生物科技有限公司 | 基于模式生物的药物抗过敏功效评价方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101153303A (zh) * | 2007-09-18 | 2008-04-02 | 江西德宇集团 | 白花檵木黄酮制作方法 |
CN101244098A (zh) * | 2008-03-11 | 2008-08-20 | 刘奇 | 一种治疗痢疾的中草药制剂 |
-
2011
- 2011-03-07 CN CN201110053465XA patent/CN102134187B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102134187A (zh) | 2011-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mitra et al. | A review on potential bioactive phytochemicals for novel therapeutic applications with special emphasis on mangrove species | |
Deng et al. | Anneslea fragrans Wall. ameliorates ulcerative colitis via inhibiting NF-κB and MAPK activation and mediating intestinal barrier integrity | |
Liu et al. | An in vivo and in vitro assessment of the anti-inflammatory, antinociceptive, and immunomodulatory activities of Clematis terniflora DC. extract, participation of aurantiamide acetate | |
CN102018759B (zh) | 迷迭香酸、含迷迭香酸的夏枯草有效组分及其制备方法和其在防治癌症术后转移方面的应用 | |
CN101637503A (zh) | 构树叶总黄酮提取物及其制备方法与应用 | |
CN108752302A (zh) | 沉香中2-(2-苯乙基)色酮类化合物的用途 | |
CN101880306B (zh) | 黄腊果皂苷类成分及其制备方法和应用 | |
CN102134187B (zh) | 檵木叶中的4-(4-羟基-3-甲氧苯基)-1-(4-羟苯基)-2,3-二甲基丁基-1-酮及其用途 | |
CN103288614B (zh) | 具有抗肿瘤活性的间苯三酚类化合物及其药物组合物 | |
CN101028322B (zh) | 毛裂蜂斗菜提取物用于制备防治肿瘤疾病药物的用途 | |
CN102775375B (zh) | 一种色酮类化合物及制备方法、应用以及所制备的抗艾滋病药物组合物和制剂 | |
CN100491364C (zh) | 蒲公英中的倍半萜内酯及其抗格兰氏阳性菌的用途 | |
CN102659802A (zh) | 香豆素木脂体类化合物的制备方法及其抗海洋污损方面的应用 | |
CN110357894B (zh) | 一种三环生物碱类化合物及其制备方法与应用 | |
CN105198943B (zh) | 一种名为茶山奈苷a的酰化黄酮糖苷及其制备方法和应用 | |
CN101787004B (zh) | 滇瑞香所含的木脂素类化合物及其制备方法和应用 | |
CN104262316A (zh) | 一种黄酮类化合物及其制备方法和应用 | |
CN108703972A (zh) | 一种黄酮-皂苷混源萜类化合物在药物制备中的应用 | |
CN105503810B (zh) | 一种具有醛基的新萜类化合物及其制备方法和应用 | |
CN101721434B (zh) | 一种阿里红有效组分及其制备方法和用途 | |
CN100471851C (zh) | 蒲公英中的木质素及其抗菌活性和医药用途 | |
CN103288615A (zh) | 单环间苯三酚类化合物及其药物组合物和其应用 | |
CN109456163B (zh) | 一种具有对称结构的环烯酮类化合物及其制备方法和应用 | |
CN102295678B (zh) | 从太白银莲花提取的三萜皂苷类化合物的用途 | |
CN103113196B (zh) | 一种连钱草酚及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HU NAN BENCAO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LI XUESONG Effective date: 20121130 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610041 CHENGDU, SICHUAN PROVINCE TO: 416000 XIANGXI TUJIA AND MIAO AUTONOMOUS PREFECTURE, HUNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121130 Address after: 416000, Xiangxi Tujia and Miao Autonomous Prefecture, Yongshun province Hunan County town Patentee after: HUNAN BENCAO PHARMACEUTICAL CO., LTD. Address before: 610041, 13-2-6C, two West Street, Sha Yan, 663, Sichuan, Chengdu, Wuhou District Patentee before: Li Xuesong |
|
DD01 | Delivery of document by public notice |
Addressee: Li Xuesong Document name: Notification of Passing Examination on Formalities |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20140307 |